Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stage II (high-risk) or stage III colorectal cancer, based on a specific internationally used staging system (TNM classification, 8th edition).
- People who have gone through the standard tests and treatments recommended by their local medical guidelines.
- People who have had surgery to remove the cancer with the goal of curing it, followed by a course of chemotherapy after surgery.
- People who have been confirmed as cancer-free at the time of joining the study.
Who may not be able to join:
- People who have not provided written agreement to participate in the trial.
- People whose cancer came back within the first 6 months after finishing their post-surgery chemotherapy.
- People who have a hereditary (inherited) colorectal cancer condition, as identified through genetic testing.
- People who have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ajay Goel, PhD, City of Hope Medical Center
Phone: 6262183452
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recurrence-Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.